|
Volumn 47, Issue , 2004, Pages 30-32
|
Pharmaceutical reversal of insulin resistance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINE;
CHOLINERGIC RECEPTOR STIMULATING AGENT;
CHOLINESTERASE INHIBITOR;
CYCLIC GMP;
GLUCOSE;
GLUTATHIONE;
HEPATIC INSULIN SENSITIZING SUBSTANCE;
INSULIN;
INSULIN SENSITIZING AGENT;
MUSCARINIC RECEPTOR;
NITRIC OXIDE DONOR;
NITRIC OXIDE SYNTHASE;
PHOSPHODIESTERASE INHIBITOR;
PROSTAGLANDIN SYNTHASE;
SUCROSE;
UNCLASSIFIED DRUG;
ADIPOSE TISSUE;
AGING;
AUTONOMIC DENERVATION;
BILE DUCT LIGATION;
CAT;
CHOLINERGIC TRANSMISSION;
CHRONIC LIVER DISEASE;
CONFERENCE PAPER;
DIET RESTRICTION;
DOG;
DRUG MECHANISM;
FETAL ALCOHOL SYNDROME;
FUNCTION TEST;
GLUCOSE TRANSPORT;
GUINEA PIG;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LIVER;
LIVER DENERVATION;
LIVER TOXICITY;
MOUSE;
PARASYMPATHETIC NERVE;
RAPID INSULIN SENSITIVITY TEST;
RAT;
RECEPTOR BLOCKING;
REGULATORY MECHANISM;
SIGNAL TRANSDUCTION;
SKELETAL MUSCLE;
SPONTANEOUSLY HYPERTENSIVE RAT;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
FOOD;
HUMANS;
INSULIN;
INSULIN RESISTANCE;
LIVER;
|
EID: 9444283195
PISSN: 00838969
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (10)
|
References (8)
|